This program discusses the role of reversal agents in the presence of life-threatening bleeds while on an anticoagulant. It focuses on managing the anticoagulated patient with life-threatening intracranial bleeding, gastrointestinal bleeding, and post-traumatic bleeding in the Emergency Department. This enduring activity was originally presented as a satellite symposium which was held during the ACEP 2022 Scientific Assembly in San Francisco, CA.

This Expert Exchange webcast is designed to help improve clinicians’ understanding of the role radiologic imaging plays in the diagnosis and management of ADPKD.

This program discusses the role of reversal agents in the presence of life-threatening bleeds while on an anticoagulant. It focuses on managing the anticoagulated patient with life-threatening intracranial bleeding, gastrointestinal bleeding, and post-traumatic bleeding in the Emergency Department. This enduring activity was originally presented as a satellite symposium which was held during the ACEP 2022 Scientific Assembly in San Francisco, CA.

This program discusses the role of reversal agents in the presence of life-threatening bleeds while on an anticoagulant. It focuses on managing the anticoagulated patient with life-threatening intracranial bleeding, gastrointestinal bleeding, and post-traumatic bleeding in the Emergency Department. This enduring activity was originally presented as a satellite symposium which was held during the ACEP 2022 Scientific Assembly in San Francisco, CA.

This program discusses the role of reversal agents in the presence of life-threatening bleeds while on an anticoagulant. It focuses on managing the anticoagulated patient with life-threatening intracranial bleeding, gastrointestinal bleeding, and post-traumatic bleeding in the Emergency Department. This enduring activity was originally presented as a satellite symposium which was held during the ACEP 2022 Scientific Assembly in San Francisco, CA.

This program discusses the role of reversal agents in the presence of life-threatening bleeds while on an anticoagulant. It focuses on managing the anticoagulated patient with life-threatening intracranial bleeding, gastrointestinal bleeding, and post-traumatic bleeding in the Emergency Department. This enduring activity was originally presented as a satellite symposium which was held during the ACEP 2022 Scientific Assembly in San Francisco, CA.

The FIDELITY pooled analysis findings demonstrated benefits in cardiovascular and kidney outcomes when nonsteroidal mineralocorticoid receptor antagonists (MRAs) were added to the mix. Tune in to hear Drs. Pam Taub, Gerasimos Filippatos, and George Bakris discuss the risk factors of chronic kidney disease, the importance of measuring eGFR and UACR, and how finerenone improves outcomes.

Newer therapeutic options are now available to treat COVID-19. Don’t panic! Drs. Charles Vega and Paul Auwaerter are here to help you successfully integrate these therapeutics into your practice. Find out how to identify patients that are at risk for severe disease and select the appropriate treatment for the patient in front of you.

Clinicians treating patients in outpatient, urgent care, and emergent care settings who encounter patients with mild to moderate disease are tasked with providing optimal care to prevent disease progression. Drs. Charles Vega and David Cennimo take us through the spectrum of COVID-19 disease and identify available treatment options for your high-risk patients.

In this program, expert faculty review and discuss real-world applications of the latest practice-changing data across different therapeutic areas within cardiovascular medicine presented at the European Society of Cardiology 2022 Meeting.